Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
15 studies found for:    lesinurad
Show Display Options
RSS Create an RSS feed from your search for:
lesinurad
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Lesinurad Tablet Relative Bioavailability
Condition: Healthy
Interventions: Drug: Lesinurad 400 mg (Site 1);   Drug: Lesinurad 400 mg (Site 2, Lot A);   Drug: Lesinurad 400 mg (Site 2, Lot B)
2 Completed Lesinurad Interaction Study With Ranitidine
Condition: Healthy
Interventions: Drug: lesinurad 400 mg;   Drug: ranitidine 150 mg;   Drug: lesinurad 400 mg + ranitidine 150 mg
3 Completed Bioavailability of Lesinurad and Intravenous [14C]Lesinurad
Condition: Healthy
Interventions: Drug: Lesinurad 400 mg;   Drug: [14C]lesinurad (100 μg per 10 mL)
4 Completed Lesinurad Tablet Bioequivalence
Condition: Healthy
Interventions: Drug: Lesinurad 400 mg (manufactured at Site 1);   Drug: Lesinurad 400 mg (manufactured at Site 2)
5 Completed Single and Multiple Dose Study in Japanese
Condition: Gout
Interventions: Drug: Lesinurad;   Drug: Placebo
6 Enrolling by invitation Lesinurad and Allopurinol Combination Extension Study in Gout
Condition: Gout
Intervention: Drug: Lesinurad
7 Enrolling by invitation Lesinurad and Febuxostat Combination Extension Study in Gout
Condition: Gout
Intervention: Drug: lesinurad
8 Completed Antacid Interaction Study
Condition: Healthy
Interventions: Drug: Lesinurad 400 mg;   Drug: Tums 500 mg and 750 mg;   Drug: MINTOX 10 mL
9 Completed Combining Lesinurad With Allopurinol in Inadequate Responders
Condition: Gout
Interventions: Drug: Lesinurad;   Drug: Placebo
10 Completed Combining Lesinurad With Allopurinol in Inadequate Responders
Condition: Gout
Interventions: Drug: Lesinurad;   Drug: Placebo
11 Completed Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
Condition: Tophaceous Gout
Interventions: Drug: Lesinurad;   Drug: Placebo
12 Completed NSAID Drug Interaction Study
Condition: Gout
Interventions: Drug: lesinurad 400 mg;   Drug: naproxen 250 mg;   Drug: indomethacin 25 mg
13 Completed Open-Label Lesinurad Monotherapy Extension Study in Gout
Condition: Gout
Intervention: Drug: lesinurad
14 Completed Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
Condition: Gout
Interventions: Drug: lesinurad;   Drug: Placebo
15 Completed Metformin and Furosemide Drug-Drug Interaction Study
Condition: Healthy
Interventions: Drug: Lesinurad 400 mg;   Drug: Metformin 850 mg;   Drug: Furosemide 40 mg

Indicates status has not been verified in more than two years